Jiangsu gdk Biotechnology Co., Ltd. (688670.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 17.07

From 52W high−15.67%

Volume2.53M

Market capCNY 1.85B

P/E (TTM)−10.4x

P/S (TTM)19.7x

Div yield—

Key dataSep 18, 2026

Open

CNY 17.07

From 52W high

−15.67%

Volume

2.53M

Market cap

CNY 1.85B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−13.2x

P/E (TTM)

−10.4x

RSI (14)

59.7

MomentumView details →

1D Return

−5.89%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

−10.4x

EV/EBITDA

−13.2x

EV/Sales

20.0x

P/S (TTM)

19.7x

P/B (TTM)

1.8x

ProfitabilityView details →

Gross Margin

62.21%

Net Margin

−166.13%

EBITDA Margin

−150.71%

ROE (TTM)

−17.02%

ROA (TTM)

−13.52%

Asset Turnover

0.08x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

−29.23%

EPS CAGR 3Y

−90.79%

EBITDA YoY

—

MomentumView details →

1D Return

−5.89%

YTD Return

—

1Y Return

—

RSI (14)

59.7

vs 50D SMA

+13.22%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.09x

Current Ratio

1.52x

Quick Ratio

1.36x

Div Yield

—

Div Rate

—

Div Growth 1Y

−44.00%

EarningsView details →

EPS (Actual)

−CNY 0.23

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

110.32M

Net Income (TTM)

−183.27M

Op. CF (TTM)

−151.57M

Next earningsOct 23, 2026 →

Latest newsMore news →

Jindike announced its H1 2026 results: revenue fell 74.15% year-on-year to 0.9109 million yuan, and net loss attributable to shareholders widened to 51.0704 million yuan from 39.6531 million yuan a year earlier.31d ago

Similar companies

Mind Medicine (MindMed) Inc.MNMD Galapagos N.V.GLPG Revolution Medicines, Inc. WarrantRVMDW Xencor, Inc.XNCR Stoke Therapeutics, Inc.STOK Galapagos N.V. Sponsored ADRLKFT Find similar companies →

Latest newsMore news →

Jindike announced its H1 2026 results: revenue fell 74.15% year-on-year to 0.9109 million yuan, and net loss attributable to shareholders widened to 51.0704 million yuan from 39.6531 million yuan a year earlier.31d ago